Healthier, Longer Lives — For More Than Humans

Modern medicine cannot be quantitative without good biomarkers. The CureForge Biomarker Discovery Institute is the federation’s research engine for finding them. Ten specialized AI systems collaborate across circulating biomarker design across proteomic and metabolomic platforms, liquid biopsy through cell-free DNA and circulating tumor DNA, digital pathology with slide-level deep learning, tissue biomarker discovery with cross-talk to the oncology and Alzheimer’s institutes, imaging biomarker discovery across MRI, CT, and PET, multi-omic biomarker fusion, the specialist track for aging biomarkers including methylation clocks coordinated with the federation’s aging-as-disease sub-institute, biomarker validation across federated cohorts, wet-lab validation routing through the federation’s physical-world integration layer, and FDA Drug Development Tool submission coordinated with the federation’s regulatory institute. Every biomarker entering federation pipelines is regulator-grade or on the path to it.

Value proposition:

• Multi-modal biomarker discovery across body fluids, tissue, and imaging
• Cross-cohort federated validation as a default
• Regulator-grade Drug Development Tool submission pipelines